NCR2 and hepatocellular carcinoma: A more in-depth analysis of ILC3 subsets based on NKp44 expression (12) revealed that the NKp44+ ILC3 population was significantly increased in HCC patients as compared to healthy controls (Figure 1D; 1.2% vs. 0.3%, p=0.017) and NKp44- ILC3s were reduced (Figure 1E; 35.9% vs 49.6%, p=<0.0001).